How Rick Perry Became a Fervent Advocate for the Psychedelic Ibogaine

The former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.

News
Ousted F.D.A. Vaccine Chief Returns to Agency

Dr. Vinay Prasad’s rehiring was an unusual instance of a federal official targeted by the right-wing activist Laura Loomer being brought back into the Trump administration.

News
RFK Jr. Announces Plan to Restrict Opioid-Like Kratom Product

Federal officials said a psychoactive ingredient in kratom had been refined and added to supplements that could quickly become addictive.

News
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancy

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts said antidepressants were safe and necessary.

News
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Says

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising medications, the Congressional Budget Office said on Friday.

News
F.D.A. Panel to Reassess Hormone Therapy Warnings

Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been overstated.

News
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.

News
Top F.D.A. Official Overrode Scientists on Covid Shots

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

News
What Makes a Food Ultraprocessed? The FDA Is About to Weigh In.

The agency is crafting a definition that could shape food policy nationwide.

News
F.D.A. Looks to A.I. to Enhance Efficiency

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.

News